PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

AMGN vs. NVAX

Last updated Feb 24, 2024

Compare and contrast key facts about Amgen Inc. (AMGN) and Novavax, Inc. (NVAX).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMGN or NVAX.

Key characteristics


AMGNNVAX
YTD Return1.19%10.21%
1Y Return25.79%-41.68%
3Y Return (Ann)11.06%-72.13%
5Y Return (Ann)12.45%-32.75%
10Y Return (Ann)11.88%-26.95%
Sharpe Ratio1.23-0.47
Daily Std Dev21.67%89.36%
Max Drawdown-78.03%-98.82%
Current Drawdown-10.20%-98.35%

Fundamentals


AMGNNVAX
Market Cap$154.98B$628.40M
EPS$12.49-$6.23
PEG Ratio2.100.00
Revenue (TTM)$28.19B$1.05B
Gross Profit (TTM)$19.92B-$156.05M
EBITDA (TTM)$12.23B-$574.87M

Correlation

0.21
-1.001.00

The correlation between AMGN and NVAX is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

AMGN vs. NVAX - Performance Comparison

In the year-to-date period, AMGN achieves a 1.19% return, which is significantly lower than NVAX's 10.21% return. Over the past 10 years, AMGN has outperformed NVAX with an annualized return of 11.88%, while NVAX has yielded a comparatively lower -26.95% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%SeptemberOctoberNovemberDecember2024February
14.49%
-36.69%
AMGN
NVAX

Compare stocks, funds, or ETFs


Amgen Inc.

Novavax, Inc.

AMGN vs. NVAX - Dividend Comparison

AMGN's dividend yield for the trailing twelve months is around 2.99%, while NVAX has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
AMGN
Amgen Inc.
2.99%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%1.53%1.65%
NVAX
Novavax, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

AMGN vs. NVAX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Amgen Inc. (AMGN) and Novavax, Inc. (NVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
AMGN
Amgen Inc.
1.23
NVAX
Novavax, Inc.
-0.47

AMGN vs. NVAX - Sharpe Ratio Comparison

The current AMGN Sharpe Ratio is 1.23, which is higher than the NVAX Sharpe Ratio of -0.47. The chart below compares the 12-month rolling Sharpe Ratio of AMGN and NVAX.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50SeptemberOctoberNovemberDecember2024February
1.23
-0.47
AMGN
NVAX

AMGN vs. NVAX - Drawdown Comparison

The maximum AMGN drawdown since its inception was -78.03%, smaller than the maximum NVAX drawdown of -98.82%. The drawdown chart below compares losses from any high point along the way for AMGN and NVAX


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2024February
-10.20%
-98.35%
AMGN
NVAX

AMGN vs. NVAX - Volatility Comparison

The current volatility for Amgen Inc. (AMGN) is 8.61%, while Novavax, Inc. (NVAX) has a volatility of 26.96%. This indicates that AMGN experiences smaller price fluctuations and is considered to be less risky than NVAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2024February
8.61%
26.96%
AMGN
NVAX